New Horizons Clinical Research recapitalized by NaviMed Capital

Dec. 2017

Client: NHCR operates multi-therapeutic clinical research sites with a depth of clinical expertise in pulmonary / respiratory studies

Role: Edgemont Partners acted as exclusive financial advisor to New Horizons Clinical Research in its recapitalization and merger to form Velocity Clinical Research, Inc. sponsored by NaviMed Capital

Location: Cincinnati, OH

Sector: Pharmaceutical Services

Lead Banker: David Blume